BIO-Europe Spring 2019: Nanoform Harnesses Physics To Enhance Drug Candidate Viability
Executive Summary
Nanoform’s chief commercial officer Christian Jones outlines how the company uses physics to enhance drug discovery and development for its pharma partners.